C5a binding nucleic acids

US8507456B2 · kind B2 · utility

Assignee

• NOXXON Pharma AG · DE

Inventors

• Werner Purschke · Berlin, DE
• Florian Jarosch · Berlin, DE
• Dirk Eulberg · Berlin, DE
• Sven Klussmann · Berlin, DE
• Klaus Buchner · Schaffhausen, CH
• Christian Maasch · Berlin, DE

Key dates

• Filing date: Sep 24, 2008
• Grant date: Aug 13, 2013
• Expiry date: Mar 31, 2029

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T436/143333
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention is related to a nucleic acid, preferably binding to C5a, selected from the group comprising type A nucleic acids, type B nucleic acids, type C nucleic acids, type D nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ.ID.No. 73 to 79.